...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products:(Date:7/25/2008)... WASHINGTON, July 25 /PRNewswire/ -- Klafter &...t ArthroCare Corporation ("ArthroCare" or the,"Com...s in the U.S. District,Court for the Western Distr...who purchased the common stock ArthroCare from Jan...tock Purchaser Class Period") and all,persons or e...
(Date:7/25/2008)... PLEASANTON, Calif., July 25 /PRNewswire-First...orld leader in device-based mechanical,circulatory...iling hearts,today announced that it will report ...irst six months of fiscal 2008 on Thursday, July 3...scuss its financial,results and operating activiti...
(Date:7/25/2008)..., OAK BROOK, Ill. July 25, 2008 The American S...ssued guidelines on the role of endoscopy in the b... obesity in the United States and the success in s...the number of weight-loss surgeries performed in t...he guidelines discuss endoscopy in the preoperativ...
(Date:7/25/2008)... SullivanCotter Releases Results of Fourth Annu... Survey, DETROIT, July 25 /PRNewswire/ -- S... its fourth annual survey of physician on-call pay...ay Survey Report. The survey report,with data fro...s physician,on-call pay practices and rates paid f...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/...eloped for mental illnesses, according to a new,re...cused on the,devastating effects that mental illne.... Nationwide, mental illness affects nearly 60 mil...rmaceutical Research and Manufacturers,of America ...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswir...oday announced the top-line results from the 52-we...following the completion of,the 301 phase 3 study ...d,safety findings and efficacy was maintained for ... the patients, global assessment scale. In,additio...
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma... imaging agents for the Positron Emission Tomograp...s for BFPET, its novel,Fluorine-18 labeled tracer ...harma,s second cardiovascular product to complete ...ging agent, designed to assess the blood flow in t...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Fir...ded late yesterday, the Board of Progen,Pharmaceut...nced that it,had discontinued the PI-88 phase 3 st...c direction to develop its existing portfolio of c...uire additional compounds and,opportunities throug...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 1Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 2Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 4Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 1Human safety prosperity depend on better ocean observing system 3A Scientists 1319 2Human safety prosperity depend on better ocean observing system 3A Scientists 1319 3Human safety prosperity depend on better ocean observing system 3A Scientists 1319 4Human safety prosperity depend on better ocean observing system 3A Scientists 1319 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 6Human safety prosperity depend on better ocean observing system 3A Scientists 1319 7Human safety prosperity depend on better ocean observing system 3A Scientists 1319 8Age burden divorce and heavy tea consumption are significant risk factors for erosive esophagitis 6850 1Dr Dello Russo Introduces the New EYE Q Lasik 901 1... June 15, 2007-Active Biotech (OMX Nordic: ACTI) p... at the annual EULAR (The,European League Against ...ular.org/">www.eular.org ) conference, June,13-16...t I-3D has a,significant inhibitory effect on dise...atoid arthritis (RA)", commented Sven,André...
...ival Benefit Demonstrated for an AI Over Tamoxifen...07: Analysis of the entire,population of a single ...st cancer can be significantly improved by switchi...alysis of the,Arimidex,-,Nolvadex 95, (ARNO 95) s...Oncology, confirms that postmenopausal women,who h...
Other Medicine Technology:New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5